| Literature DB >> 24457528 |
Ivan Montoliu1, Max Scherer, Fiona Beguelin, Laeticia DaSilva, Daniela Mari, Stefano Salvioli, Francois-Pierre J Martin, Miriam Capri, Laura Bucci, Rita Ostan, Paolo Garagnani, Daniela Monti, Elena Biagi, Patrizia Brigidi, Martin Kussmann, Serge Rezzi, Claudio Franceschi, Sebastiano Collino.
Abstract
As centenarians well represent the model of healthy aging, there are many important implications in revealing the underlying molecular mechanisms behind such successful aging. By combining NMR metabonomics and shot-gun lipidomics in serum we analyzed metabolome and lipidome composition of a group of centenarians with respect to elderly individuals. Specifically, NMR metabonomics profiling of serum revealed that centenarians are characterized by a metabolic phenotype distinct from that of elderly subjects, in particular regarding amino acids and lipid species. Shot- gun lipidomics approach displays unique changes in lipids biosynthesis in centenarians, with 41 differently abundant lipid species with respect to elderly subjects. These findings reveal phospho/sphingolipids as putative markers and biological modulators of healthy aging, in humans. Considering the particular actions of these metabolites, these data are suggestive of a better counteractive antioxidant capacity and a well-developed membrane lipid remodelling process in the healthy aging phenotype.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24457528 PMCID: PMC3927806 DOI: 10.18632/aging.100630
Source DB: PubMed Journal: Aging (Albany NY) ISSN: 1945-4589 Impact factor: 5.682
Clinical characteristics of the aging cohort. Values are presented as mean (±SD) with the range in parentheses. P value is as follow: *p<0.05, **p<0.01, ***p<0.001.
| Centenarians | Elderly | |
|---|---|---|
| Gender, | 22/76 | 85/111 |
| BMI, | 24.0±3.8 (17.8-29.2) | 26.8±1.5 (16.1-49.7) |
| HOMA | 1.97±0.66 (0.3-2.1) | 3.0±2.8 (0.7-16.4) |
| Cholesterol, | 185.0±32.7 (112-264) | 201.0±37.2 (5-335) |
| Triglycerides, | 114.4±46.1 (60-283) | 129.9±65.7 (44-530) |
| HDL-cholesterol, | 48.2±13.1 (25-99) | 55.2+20.4 (20-147) |
| LDL- cholesterol, | 105.6±35.1 (75-165 | 118.7±45.7 (23.8-199) |
| CRP, mg/L | 5.41±4.9 (0.28-19.9) | 3.24±3.9 (0.11-19.1) |
| A-SAA, | 527±707 (15.5-3821) | 142.9±187 (0.01-1318) |
| MMSE | 21.2±4.2 (15.2-23.2) | 27.16±1.53 (23-29.7) |
| Cardiovascular therapy, | 33 | 67 |
| Irregular heart rhythm, | 14 | 21 |
| Diabetes | 5 | 11 |
Legend: BMI=body mass index, HOMA=Homeostatic Model Assessment index, HDL= high density lipoprotein, LDL= low density lipoprotein,CRP=C reactive protein, A-SAA= Serum amyloid A (SAA) proteins.
MMSE= Cognitive function measure using the Mini-Mental State Examination (MMSE). The score used in the analysis was corrected by age and years of educations according to Magni et. al for old people. MMSE for elderly cognitive impairment was graded as severe (score 0–17), mild (score 18–23), or not present (score 24–30). MMSE for centenarians ≥ 20 absence of severe cognitive decline; <12 presence of severe cognitive decline according to Franceschi et al.2000a.
Diabetes mellitus: history of diabetes, fasting glucose plasma ≥126mg/dl
Figure 1Bar plots representing differences in serum markers of longevity as per 1H-NMR. All significantly regulated metabolites and statistical changes are listed in Table S2.
Figure 2Differences in mean (μM) standardized lipids value between elderly and centenarians. Represented is median value (μM) of each metabolite divided it by the IQR range of the distribution. All significantly regulated metabolites are listed in Table S5.